Buy 5 or more, save 35% · code

Back to Catalog

Peptides

Selank 5 mg

$65Per Unit

High-purity regulatory peptide with documented GABAergic and monoaminergic receptor interaction profiles for laboratory research.

Lot SLK2026-05E · COA on request
Lyophilized heptapeptide, sterile vial, 5 mg fill
2–8°C

1 × $65.00 = $65.00

4 more units of anything - mix and match - unlocks 35% off with code EHAB35.

Selank 5 mg

$65.00

Research use only
Selank 5 mg research packaging
Lyophilized heptapeptide, sterile vial, 5 mg fill
Anubis Research Labs

Documentation

The certificate of analysis for the current lot (Lot SLK2026-05E) is sent on request, so you can review identity and purity testing before you order.

Request the lot COA

Research summary

Selank(TP-7, tuftsin analog)

Regulatory status
Not approved in the U.S. FDA lists selank acetate among substances that may present significant safety risks in compounding.
Strongest evidence
Animal studies; little English-language human data
Overview

Selank is a synthetic analog of tuftsin, an immune-system peptide, developed in Russia and studied mainly for anxiety-related behavior.

What researchers study it for
  • Anxiety-like behavior (rat models)
  • Opioid withdrawal signs (rats)
Mechanism

Proposed effects on GABAergic signaling and cytokines in animal studies.

Evidence (2)
  1. Animal study

    Chronic stress model (Behav Neurol 2017)

    Enhanced the anxiety-reducing effect of diazepam in rats under chronic mild stress.[1]

  2. Animal study

    Morphine withdrawal (2022)

    Attenuated aversive signs of morphine withdrawal in rats.[2]

Limitations of the evidence
  • Independent human trials are lacking.
  • Products on this site are sold for laboratory research only. They are not the medicines used in the trials above, and those results do not apply to research material.
Sources (3)
  1. 1.Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in RatsKasian A et al. Behav Neurol. 2017 Animal study
  2. 2.Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in RatsKonstantinopolsky MA et al. Bull Exp Biol Med. 2022 Animal study
  3. 3.Certain bulk drug substances for use in compounding that may present significant safety risks (lists selank acetate)U.S. FDA, page current as of Apr 22, 2026 Regulatory
Every published studyPubMed search: Selank(opens in a new tab)Every registered trialClinicalTrials.gov search: Selank(opens in a new tab)

Reviewed 2026-10-02. Summaries describe published research and regulatory records; they are not medical advice and do not describe how to use this product. Sold for laboratory research use only.